398 related articles for article (PubMed ID: 24055626)
1. Platelet glycoprotein Ibα ectodomain shedding and non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist devices.
Hu J; Mondal NK; Sorensen EN; Cai L; Fang HB; Griffith BP; Wu ZJ
J Heart Lung Transplant; 2014 Jan; 33(1):71-9. PubMed ID: 24055626
[TBL] [Abstract][Full Text] [Related]
2. Association of Oxidative Stress and Platelet Receptor Glycoprotein GPIbα and GPVI Shedding During Nonsurgical Bleeding in Heart Failure Patients With Continuous-Flow Left Ventricular Assist Device Support.
Mondal NK; Chen Z; Trivedi JR; Sorensen EN; Pham SM; Slaughter MS; Griffith BP; Wu ZJ
ASAIO J; 2018; 64(4):462-471. PubMed ID: 28953486
[TBL] [Abstract][Full Text] [Related]
3. Intraplatelet reactive oxygen species, mitochondrial damage and platelet apoptosis augment non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist device.
Mondal NK; Sorensen EN; Hiivala NJ; Feller ED; Pham SM; Griffith BP; Wu ZJ
Platelets; 2015; 26(6):536-44. PubMed ID: 25167344
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress induced modulation of platelet integrin α2bβ3 expression and shedding may predict the risk of major bleeding in heart failure patients supported by continuous flow left ventricular assist devices.
Mondal NK; Chen Z; Trivedi JR; Sorensen EN; Pham SM; Slaughter MS; Griffith BP; Wu ZJ
Thromb Res; 2017 Oct; 158():140-148. PubMed ID: 28915447
[TBL] [Abstract][Full Text] [Related]
5. Acquired platelet defects are responsible for nonsurgical bleeding in left ventricular assist device recipients.
Arias K; Sun W; Wang S; Sorensen EN; Feller E; Kaczorowski D; Griffith B; Wu ZJ
Artif Organs; 2022 Nov; 46(11):2244-2256. PubMed ID: 35596611
[TBL] [Abstract][Full Text] [Related]
6. The Glycoprotein (GP)Ib-IX-V Complex on Platelets: GPIbα Protein Expression Is Reduced in HeartMate 3 Patients with Bleeding Complications within the First 3 Months.
Klaeske K; Brade A; Eifert S; Jawad K; Saeed D; Haunschild J; Sieg F; Borger MA; Dieterlen MT
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982712
[TBL] [Abstract][Full Text] [Related]
7. Device-induced platelet dysfunction in patients after left ventricular assist device implantation.
Klaeske K; Dieterlen MT; Eifert S; Scholz U; Garbade J; Jawad K; Sieg F; Borger MA; Meyer AL
J Thromb Haemost; 2021 May; 19(5):1331-1341. PubMed ID: 33636040
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic insight of platelet apoptosis leading to non-surgical bleeding among heart failure patients supported by continuous-flow left ventricular assist devices.
Mondal NK; Li T; Chen Z; Chen HH; Sorensen EN; Pham SM; Sobieski MA; Koenig SC; Slaughter MS; Griffith BP; Wu ZJ
Mol Cell Biochem; 2017 Sep; 433(1-2):125-137. PubMed ID: 28343311
[TBL] [Abstract][Full Text] [Related]
9. Decreased Platelet Specific Receptor Expression of P-Selectin and GPIIb/IIIa Predict Future Non-Surgical Bleeding in Patients after Left Ventricular Assist Device Implantation.
Klaeske K; Meyer AL; Saeed D; Eifert S; Jawad K; Sieg F; Haunschild J; Borger MA; Dieterlen MT
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142161
[TBL] [Abstract][Full Text] [Related]
10. Mechanical circulatory support is associated with loss of platelet receptors glycoprotein Ibα and glycoprotein VI.
Lukito P; Wong A; Jing J; Arthur JF; Marasco SF; Murphy DA; Bergin PJ; Shaw JA; Collecutt M; Andrews RK; Gardiner EE; Davis AK
J Thromb Haemost; 2016 Nov; 14(11):2253-2260. PubMed ID: 27601054
[TBL] [Abstract][Full Text] [Related]
11. Device-induced platelet dysfunction in mechanically assisted circulation increases the risks of thrombosis and bleeding.
Chen Z; Zhang J; Kareem K; Tran D; Conway RG; Arias K; Griffith BP; Wu ZJ
Artif Organs; 2019 Aug; 43(8):745-755. PubMed ID: 30805954
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding.
Bartoli CR; Kang J; Restle DJ; Zhang DM; Shabahang C; Acker MA; Atluri P
JACC Heart Fail; 2015 Nov; 3(11):860-9. PubMed ID: 26454844
[TBL] [Abstract][Full Text] [Related]
13. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients.
Crow S; Chen D; Milano C; Thomas W; Joyce L; Piacentino V; Sharma R; Wu J; Arepally G; Bowles D; Rogers J; Villamizar-Ortiz N
Ann Thorac Surg; 2010 Oct; 90(4):1263-9; discussion 1269. PubMed ID: 20868825
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of von Willebrand factor profiles after implantation of left ventricular assist device and total artificial heart.
Reich HJ; Morgan J; Arabia F; Czer L; Moriguchi J; Ramzy D; Esmailian F; Lam L; Dunhill J; Volod O
J Thromb Haemost; 2017 Aug; 15(8):1620-1624. PubMed ID: 28586149
[TBL] [Abstract][Full Text] [Related]
15. Shear-induced interaction of platelets with von Willebrand factor results in glycoprotein Ibalpha shedding.
Cheng H; Yan R; Li S; Yuan Y; Liu J; Ruan C; Dai K
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2128-35. PubMed ID: 19820200
[TBL] [Abstract][Full Text] [Related]
16. Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradation.
Kang J; Zhang DM; Restle DJ; Kallel F; Acker MA; Atluri P; Bartoli CR
J Thorac Cardiovasc Surg; 2016 Jun; 151(6):1747-1754.e1. PubMed ID: 26971377
[TBL] [Abstract][Full Text] [Related]
17. Effects of HeartWare ventricular assist device on the von Willebrand factor: results of an academic Belgian center.
Esmaeilzadeh F; Wauters A; Wijns W; Argacha JF; van de Borne P
BMC Cardiovasc Disord; 2016 Aug; 16(1):155. PubMed ID: 27485105
[TBL] [Abstract][Full Text] [Related]
18. Increased cyclic guanosine monophosphate levels and continuous-flow left-ventricular assist devices: Implications for gastrointestinal bleeding.
Grosman-Rimon L; Tumiati LC; Fuks A; Jacobs I; Lalonde SD; Cherney DZ; Rao V
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):219-27. PubMed ID: 26515873
[TBL] [Abstract][Full Text] [Related]
19. Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis.
Bartoli CR; Zhang DM; Hennessy-Strahs S; Kang J; Restle DJ; Bermudez C; Atluri P; Acker MA
Circ Heart Fail; 2018 Sep; 11(9):e004638. PubMed ID: 30354363
[TBL] [Abstract][Full Text] [Related]
20. Detection of acquired von Willebrand syndrome after ventricular assist device by total thrombus-formation analysis system.
Takashio S; Kaikita K; Nishi M; Morioka M; Higo T; Shiose A; Doman T; Horiuchi H; Fukui T; Tsujita K
ESC Heart Fail; 2020 Oct; 7(5):3235-3239. PubMed ID: 32700467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
